
GC15814
Pamapimod
Also listed as Pamapimod (R-1503, Ro4402257)
Pamapimod (R-1503, Ro4402257) (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1·3 nM and 120 nM for p38α and p38β, respectively
ChemicalCAS449811-01-2MW406.38FormulaC19H20F2N4O4
- CAS number
- 449811-01-2
- Molecular weight
- 406.38
- Formula
- C19H20F2N4O4
- Solubility
- DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS(pH 7·2) (1:3): 0·25 mg/ml,Ethanol: 0·33 mg/ml
- InChIKey
- JYYLVUFNAHSSFE-UHFFFAOYSA-N
- Catalogue number
- GC15814
- Brand
- GLPBIO
Computed properties PubChem CID 16220188 · XLogP 2.4 · TPSA 108 Ų · H-bond donors 3
- XLogP
- 2.4
- TPSA
- 108 Ų
- H-bond donors
- 3
- H-bond acceptors
- 9
- Rotatable bonds
- 8
- Heavy atoms
- 29
SMILES CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC(CCO)CCO
Computed descriptors from PubChem (CID 16220188), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il